🇺🇸 FDA

Company profile · Sponsor

Merz

Merz Pharmaceuticals GmbH

EF2E3EC · EMA pharma Frankfurt am Main, DE
Pipeline
2
Drugs
0
Patents
0

Quick answer

Merz (EF2E3EC) is a pharma company. headquartered in Frankfurt am Main, DE. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EF2E3EC
Exchange EMA
Company type pharma
Headquarters Frankfurt am Main, DE

Pipeline (2)

Search pipeline →

  1. XEOMIN 200 V pulveris injekciju šķīduma pagatavošanai, Placebo to NT201, XEOMIN, 200 jednostek, proszek do sporządzania roztworu do wstrzykiwań

    Merz

    Pediatric lower limb (LL) spasticity (SP) caused by cerebral palsy (CP)

    phase 3 small molecule active

    1 trial

  2. XEOMIN 200 jednotek prášek pro injekční roztok, XEOMIN, 200 jednostek, proszek do sporządzania roztworu do wstrzykiwań, XEOMEEN 200 eenheden poeder voor oplossing voor injectie, XEOMIN 200 egység por oldatos injekcióhoz, XEOMIN 200 jednotiek prášok na injekčný roztok, XEOMIN 200 unidades polvo para solución inyectable, XEOMEEN 200 unités poudre pour solution injectable, XEOMIN 200 Einheiten Pulver zur Herstellung einer Injektionslösung, XEOMIN 200 unités, poudre pour solution injectable, XEOMIN, 200 unità,

    Merz

    Lower limb spasticity

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is Merz?

Merz (EF2E3EC) is a pharma company. headquartered in Frankfurt am Main, DE. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Merz sponsor?

We track 2 ClinicalTrials.gov-linked programs for Merz, including XEOMIN 200 V pulveris injekciju šķīduma pagatavošanai, Placebo to NT201, XEOMIN, 200 jednostek, proszek do sporządzania roztworu do wstrzykiwań and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Merz company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.